Childhood Asthma India — Triggers, Inhalers, Spacer & School Asthma Action Plan Guide

Last Updated: March 2026 | Reading Time: 9 minutes | ~2,000 words

Asthma is the most common chronic disease of childhood globally — and in India, it affects an estimated 15–20 million children, representing 10–15% of the paediatric population. Despite being highly treatable, childhood asthma accounts for a disproportionate burden of school absences, emergency hospital visits, and impaired physical development — primarily because of undertreated persistent asthma. India has a unique paediatric asthma landscape: the rapid urban expansion has brought air pollution exposure to levels that trigger and worsen asthma; the cultural preference for nebulisers over inhalers delays proper management; and the stigma around asthma in schools and sports leads to inadequate disclosure and dangerous under-preparedness. This guide addresses the clinical essentials for parents, teachers, and healthcare workers managing children with asthma in India.

Asthma Severity Classification in Children

Common Asthma Triggers in Indian Children

Inhalers vs Nebulisers — The India Debate

One of the most important and most misunderstood issues in Indian paediatric asthma management is the widespread preference for nebulisers over inhalers — a preference that is both medically suboptimal and practically inconvenient: Medical evidence: Multiple high-quality studies show that a metered-dose inhaler (MDI/pMDI) used with a spacer device delivers medication as effectively as a nebuliser for acute asthma attacks in children — and produces fewer side effects (less systemic absorption with correct spacer technique vs nebuliser). GINA (Global Initiative for Asthma) guidelines clearly state: in mild-moderate acute asthma, MDI + spacer is the preferred treatment over nebuliser. Why Indian parents and doctors prefer nebulisers: Nebuliser “looks more powerful” — parents associate the vapour cloud with more medicine; inhalers look too simple to be effective. Lack of spacer use knowledge — children who use MDI without a spacer get very poor lung delivery (only 5–10%); with a spacer, delivery improves to 30–40%. Aerochamber/spacer devices not always supplied with inhaler prescription; some physicians don’t teach spacer technique. Nebulisers are easily available and rented at ₹500–1,000/month in India. The correct answer: MDI + spacer (+ face mask for <5 years; mouthpiece for 5+) should be standard treatment. Nebulisers are reserved for: severe acute attacks where child cannot cooperate with MDI+spacer; hospital settings with oxygen-driven nebulisation; specific medications not available in MDI formulation. Spacers available in India: Aerochamber Plus (₹1,200–2,000 — reusable), Volumatic (₹500–800), Babyhaler (₹1,000–1,500 with face mask for infants); basic spacer can be made from a 500mL plastic bottle with hole for MDI at one end.

Frequently Asked Questions

Do inhaled steroids stunt a child’s growth?

This is the single most common reason for poor treatment adherence in childhood asthma in India — parents discontinuing inhaled corticosteroid (ICS) controllers due to fear that steroids will stunt their child’s growth. Understanding the evidence is critical: The evidence on growth: High-quality long-term studies, including the largest — the Childhood Asthma Management Program (CAMP study) — show that children using low-to-medium dose inhaled corticosteroids (budesonide, beclomethasone, fluticasone) have a small reduction in growth velocity in the first 1–2 years of treatment: approximately 1–1.3 cm total effect on adult height. This effect is primarily a mild delay in growth velocity (tempo) rather than permanent stunting. The prepubertal timing effect matters — earlier start may show slightly more effect on growth rate, but catch-up occurs. Final adult height in most studies is not significantly different from control children. The comparison that matters: Untreated or undertreated moderate-severe asthma causes: Chronic hypoxia during attacks → impairs growth and brain development. Sleep disruption from nocturnal symptoms → reduces GH (growth hormone) secretion at night (GH secretion is predominantly during deep sleep). Systemic oral steroids required for repeated exacerbations → far more growth-suppressive than inhaled steroids at equivalent effect size. School absences → developmental delays. Physical deconditioning. A child on appropriate ICS therapy grows nearly normally. A child with uncontrolled asthma from ICS refusal grows less well, has more oral steroids, misses more school, and suffers more. The message for parents: Inhaled corticosteroids at recommended low-to-medium doses for childhood asthma are safe. The 1cm growth effect is real but small and does not translate to permanent stunting in most children. Stopping ICS because of growth concerns — without medical discussion — leads to uncontrolled asthma which has far more significant consequences. Discuss dose optimisation (lowest effective dose) and growth monitoring with your paediatrician — but do not stop ICS unilaterally.

Can children with asthma play sports?

Yes — and they should. Exercise is beneficial for asthmatic children and should not be restricted with appropriate management: The misconception: Many Indian children with asthma are told by well-meaning parents and teachers to sit out of PE class, avoid cricket and sports, and not run. This leads to physical deconditioning, weight gain (which worsens asthma), social isolation, and poor self-image — all of which can worsen asthma outcomes over time. Exercise-induced bronchospasm (EIB) — what happens: Exercise → increased ventilation → inhalation of dry, cool air → drying of airway surface → mast cell activation → histamine and leukotrienes → bronchospasm. This typically occurs 5–10 minutes after stopping exercise (not during). EIB affects most children with asthma but does not mean they should avoid exercise — it means they need pre-treatment. Pre-treatment protocol (Pre-exercise salbutamol): 2 puffs of salbutamol (SABA) via MDI+spacer 15 minutes before exercise → prevents EIB in 80–90% of children. This is standard GINA-recommended practice. Every asthmatic child participating in sport should have a reliever inhaler available at the game/practice venue. Exercise recommendation for asthmatic children: Aerobic exercise 3–5 days/week at moderate intensity is recommended — it improves lung function, reduces airway inflammation (through anti-inflammatory exercise physiology), and improves asthma control over time. Swimming is the sport most commonly first recommended for asthmatic children: warm, humid air reduces EIB trigger; breathing pattern training benefits; full physical activity. Cricket, football, and cycling are also manageable with correct pre-treatment. Marathon running and cold-air winter sports require more careful management. Communicating with school: Provide school sports teacher with written asthma action plan; child should have inhaler accessible (in bag, not locked in medical room); inform teacher of pre-exercise protocol; child should never be made to exercise without access to reliever inhaler.

When is an asthma attack an emergency in a child?

Recognising asthma severity and knowing when to go to hospital immediately is the most life-saving knowledge for parents of asthmatic children: Mild attack — manage at home: Mild wheeze or cough; child can speak in full sentences; no significant breathing difficulty; oxygen saturation (if measured) >95%; peak flow >80% of personal best. Action: 2–4 puffs salbutamol MDI+spacer every 20 minutes × 3 doses; observe 1 hour; if improving and SABA effect lasts 3–4 hours without return of symptoms — reassess with doctor within 24 hours. Moderate attack — go to hospital/clinic soon (within hours): Breathlessness affecting walking or normal talk; child can only speak in short phrases; using accessory muscles (neck muscles tightening, intercostal recession — visible spaces between ribs pulling in on inspiration); peak flow 40–80%. Action: 4–8 puffs salbutamol every 20 minutes while travelling to hospital; do NOT delay emergency assessment waiting to see “if it gets better.” Severe/Life-threatening attack — EMERGENCY — Call 108 immediately: 🔴 Unable to speak (one-word sentences only); 🔴 Visibly struggling to breathe — tripod position (leaning forward on hands); 🔴 Blue lips or fingertips (cyanosis — oxygen saturation <90%); 🔴 Silent chest on auscultation (no wheeze — airflow so reduced the wheeze stops — most dangerous sign); 🔴 Confused, drowsy, or exhausted child; 🔴 Peak flow <40%; 🔴 No response to 6–8+ puffs salbutamol in 15 minutes. Emergency action: Continue salbutamol via MDI+spacer en route; call 108; do NOT give child food or water; keep child sitting up or in position of comfort; oxygen if available. Hospital management: Oxygen, nebulised salbutamol + ipratropium, IV/oral systemic corticosteroid, IV magnesium sulphate for severe attacks, IV aminophylline, ICU admission for life-threatening attacks. Post-attack follow-up is mandatory: Every acute asthma attack is a signal of inadequate preventive therapy — escalate controller medication after recovery.

Is childhood asthma cured at puberty?

The relationship between childhood asthma and adult outcomes is more nuanced than the popular belief that “children outgrow asthma at puberty”: What actually happens at puberty: Approximately 50–70% of children with mild-intermittent asthma in childhood experience significant improvement or apparent remission during adolescence (particularly in boys who have more rapid airway growth at puberty — airway diameter increases relative to tidal volume → reduced bronchoconstriction). This improvement is often interpreted as “outgrowing” asthma — but it is physiological remission, not cure. The relapse story: Studies consistently show that 40–60% of adults who had “outgrown” childhood asthma experience recurrence of symptoms by age 40–50. Triggers for relapse: smoking; occupational exposures (dusts, chemicals, spray paints — construction workers, hairdressers, bakers face high occupational asthma risk); significant allergen exposure; recurrent respiratory infections. The underlying airway hyperresponsiveness persists even in clinical remission — it takes only a sufficient provocation to re-express as symptomatic asthma. Who is less likely to achieve remission: Children with severe persistent asthma; those with multiple sensitisations; girls (hormone effects at puberty less protective for girls vs boys); children with comorbid eczema + allergic rhinitis (atopic march — these children have strong allergic constitution that predisposes to lifelong atopy); children with significant airway remodelling from undertreated chronic asthma. What this means in practice: Do not stop controller medications at puberty without specialist review just because “asthma seems gone.” Gradual step-down under physician supervision is appropriate. Maintain asthma action plan and reliever inhaler access even in apparent remission, especially during URTI season. Advise adolescents to avoid smoking completely — the single biggest risk factor for adult asthma recurrence. Monitor lung function with spirometry — apparent clinical remission may mask subclinical airflow limitation.

How should parents create an Asthma Action Plan for school?

An Asthma Action Plan (AAP) is a written document — created by the child’s paediatrician or pulmonologist — that specifies exactly what to do based on the child’s asthma symptoms. It is the most important safety tool for an asthmatic child at school: Components of a complete AAP: Green Zone (all clear — no symptoms): Child’s regular daily medications (name, device, dose, timing); regular pre-exercise salbutamol protocol; peak flow value if measurable. Yellow Zone (caution — mild-moderate symptoms): When to use reliever inhaler; doses to give; how many times; how long to wait before progressing to Red Zone. Red Zone (danger — emergency): Specific symptoms that indicate emergency; call 108 immediately; doses of salbutamol to give en route; who to call (parents — phone numbers; emergency contact). India-specific AAP considerations: Provide TWO copies — one for class teacher, one for school medical room. Provide reliever inhaler + spacer to be kept at school (not in the locked medical cabinet — accessible to class teacher). Ensure teacher has basic training: how to use MDI+spacer, how to recognise a severe attack, when to call 108. Provide annual update at each academic year beginning — medications may change over summer. Address Diwali firecracker period specifically — many children need increased vigilance during October-November. Address any activity restrictions explicitly — many school staff unnecessarily restrict asthmatic children from sports without understanding the management protocol. Digital resources: The National Asthma Council India-approved AAP template is available through IAP (Indian Academy of Pediatrics) website. Asthmatic children should also have a medical ID bracelet or card in their school bag identifying their condition and reliever inhaler location. Schools in India are encouraged (though not yet legally mandated) to have asthma first aid training for staff — advocating for this policy at the school PTA level is an impactful parent action.

What to Read Next

• Adult Asthma India — The Same Condition in Adults: Management & Controller Therapy
• Eczema — Atopic March: Infantile Eczema → Childhood Asthma → Adult Allergic Rhinitis Progression
• Food Allergy — Severe Food Allergy in Children Mimics Asthma; Both Need School Action Plans
• Vitamin D — Low Vitamin D is Associated With Higher Asthma Severity and Exacerbation Rate
• Anxiety — Asthma Anxiety Cycle: Breathlessness Triggers Panic, Panic Worsens Breathlessness

An asthmatic child who is well-controlled plays cricket in the school team. An asthmatic child who is undertreated sits on the bench, misses school, and develops anxiety about physical activity that persists into adulthood. The difference is a parent who knows that ICS does not stunt growth, that a spacer works as well as a nebuliser, and that pre-exercise salbutamol allows full participation. This article is for that parent.

About This Guide: Written by the StudyHub Health Editorial Team (studyhub.net.in) based on GINA (Global Initiative for Asthma) 2024 Paediatric Guidelines, IAP (Indian Academy of Pediatrics) Asthma guidelines, and NCAP (National Asthma Council India) recommendations. Last updated: March 2026.

Authoritative Sources: GINA — Global Initiative for Asthma | IAP — Indian Academy of Pediatrics | National Asthma Council India

🚨 Asthma Emergency Signs in Children: Blue lips/fingertips, silent chest (wheeze suddenly stops), unable to speak more than one word, or severe breathing effort = Call 108 immediately. Give salbutamol while waiting. Do not leave child alone.

⚕️ Medical Disclaimer: This guide is for parents and caregivers for general information. Asthma diagnosis and management must be supervised by a paediatrician or paediatric pulmonologist. Never change inhaled corticosteroid doses without medical guidance. Reliever inhalers should always be prescribed and supervised by a physician.